NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), today announced that Mary Anne Heino, President and Chief Executive Officer, and John Bakewell, Chief Financial Officer, will participate in two upcoming conferences. The sessions will include a corporate overview followed by a question and answer discussion.
The sessions will take place as follows:
- September 9, at 1:45 p.m. ET - Wells Fargo 2015 Healthcare Conference in Boston; and
- September 10, at 8:30 a.m. ET - Baird 2015 Healthcare Conference in New York.
To access a live webcast of the discussions, please visit the Company’s website at www.lantheus.com. A replay of the webcasts will be available on the Company’s website for 30 days following the live discussions.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc. (“LMI”), which is a global leader in developing, manufacturing, selling and distributing innovative diagnostic imaging agents and products. LMI provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases. LMI’s key products include the echocardiography contrast agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs.
The Company has more than 500 employees worldwide with headquarters in North Billerica, Massachusetts, and offices in Puerto Rico, Canada and Australia. For more information, visit www.lantheus.com.